Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%

CVE-2021-2040

CVSS 6.1 · Medium EPSS 0.58% · P69
Get alerts for future matching vulnerabilitiesLog in to subscribe

I. Basic Information for CVE-2021-2040

Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
Vulnerability in the Oracle Argus Safety product of Oracle Health Sciences Applications (component: Case Form, Local Affiliate Form). The supported version that is affected is 8.2.2. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Argus Safety. Successful attacks require human interaction from a person other than the attacker and while the vulnerability is in Oracle Argus Safety, attacks may significantly impact additional products. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Argus Safety accessible data as well as unauthorized read access to a subset of Oracle Argus Safety accessible data. CVSS 3.1 Base Score 6.1 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N).
Source: NVD (National Vulnerability Database)
CVSS Information
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
Oracle Health Sciences Applications和Safety 授权问题漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Oracle Health Sciences Applications是美国甲骨文(Oracle)公司的一套用于医疗保健行业的临床研发解决方案。 Oracle Health Sciences Applications 的 Oracle Argus Safety 组件中存在授权问题漏洞,该漏洞允许未经身份验证的攻击者过HTTP进行网络访问,从而危及Oracle Argus的安全性。以下产品及版本受到影响:Oracle Argus Safety--Case Form, Local Affiliate Form
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)

Affected Products

VendorProductAffected VersionsCPESubscribe
Oracle CorporationArgus Safety 8.2.2 -

II. Public POCs for CVE-2021-2040

#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC

III. Intelligence Information for CVE-2021-2040

登录查看更多情报信息。

Same Patch Batch · Oracle Corporation · 2021-01-20 · 136 CVEs total

CVE-2020-147569.8 CRITICALOracle Fusion Middleware 授权问题漏洞
CVE-2021-20649.8 CRITICALOracle Fusion Middleware WebLogic Server 授权问题漏洞
CVE-2021-19949.8 CRITICALOracle Fusion Middleware WebLogic Server 安全漏洞
CVE-2021-20479.8 CRITICALOracle Fusion Middleware 安全漏洞
CVE-2021-21089.8 CRITICALOracle Fusion Middleware 组件授权问题漏洞
CVE-2021-20299.8 CRITICALOracle E-Business Suite 安全漏洞
CVE-2021-20759.8 CRITICALOracle Fusion Middleware 安全漏洞
CVE-2021-21009.1 CRITICALOracle E-Business Suite和Oracle One-to-One Fulfillment 授权问题漏洞
CVE-2021-21019.1 CRITICALOracle E-Business Suite 组件安全漏洞
CVE-2021-20358.8 HIGHOracle Database Server 安全漏洞
CVE-2021-20678.6 HIGHOracle Fusion Middleware 组件授权问题漏洞
CVE-2021-20688.6 HIGHOracle Fusion Middleware 授权问题漏洞
CVE-2021-20668.6 HIGHOracle Fusion Middleware 授权问题漏洞
CVE-2021-20698.6 HIGHOracle Fusion Middleware 安全漏洞
CVE-2021-20638.4 HIGHOracle PeopleSoft Enterprise PeopleTools 安全漏洞
CVE-2021-20188.3 HIGHOracle Database Server 授权问题漏洞
CVE-2021-20908.2 HIGHOracle E-Business Suite 组件授权问题漏洞
CVE-2021-20858.2 HIGHOracle E-Business Suite 组件访问控制错误漏洞
CVE-2021-20848.2 HIGHOracle E-Business Suite CRM Technical Foundation 授权问题漏洞
CVE-2021-20838.2 HIGHOracle E-Business Suite 安全漏洞

Showing top 20 of 136 CVEs. View all on vendor page → →

IV. Related Vulnerabilities

V. Comments for CVE-2021-2040

No comments yet


Leave a comment